Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 92093-23-7 | MDL No. : | MFCD09743652 |
Formula : | C8H9BrO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZDPJGAWPRHNQHI-UHFFFAOYSA-N |
M.W : | 217.06 | Pubchem ID : | 11148651 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 46.24 |
TPSA : | 40.46 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.86 cm/s |
Log Po/w (iLOGP) : | 1.59 |
Log Po/w (XLOGP3) : | 1.08 |
Log Po/w (WLOGP) : | 1.15 |
Log Po/w (MLOGP) : | 1.68 |
Log Po/w (SILICOS-IT) : | 1.89 |
Consensus Log Po/w : | 1.48 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.14 |
Solubility : | 1.58 mg/ml ; 0.00728 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.52 |
Solubility : | 6.53 mg/ml ; 0.0301 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.56 |
Solubility : | 0.598 mg/ml ; 0.00275 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.83 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97% | With carbonylhydrido(tetrahydroborato)[bis(2-diphenylphosphinoethyl)-amino]ruthenium(II); hydrogen; sodium t-butanolate In methanol at 80℃; for 12 h; Glovebox; Autoclave | General procedure: A glass liner containing a stir bar was charged with substrate (0.5 mmol), base (0.05mmol), Ru-MACHO (5 umol) and MeOH (0.5 mL) in a glove box. The glass linerwas then placed into an autoclave followed by degassing with H2 three times. Thehydrogenation was carried out at 10-50 bar H2 with stirring at 25oC or 80oC for 12-24h. After the reaction finished, the autoclave was allowed to cool down to r.t. Thehydrogen gas was then carefully released in a fume hood, and the solution transferredto a flask with H2O (2 ml), extracted with EA (3x5 ml), dried with Na2SO4 andconcentrated in vacuo to afford the pure product 2a-2s or 3a-3s. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
28% | Stage #1: With osmium(VIII) oxide; 4-methylmorpholine N-oxide In water; acetone; <i>tert</i>-butyl alcohol at 20℃; for 16 h; Stage #2: With hydrogenchloride In water; acetone; <i>tert</i>-butyl alcohol |
4-Bromostyrene (1.0Og, 5.46 mmol) was dissolved in 25 mis of 2: 1 water acetone. To this was added 4-methylmorpholine N-oxide (0.704 g, 6.01 mmole) and osmium tetroxide (0.167 g, 0.061 mmole, 2.5percent in t-BuOH). This mixture was stirred at room temperature for 16 hours, then diluted with EtOAc, washed once with IN aq. HCl, once with saturated sodium bicarbonate solution, dried over sodium sulfate and concentrated under reduced pressure. The resulting crude product was purified by Flash 40 Biotage ( 4OM cartridge, 100percent EtOAc as the eluant) to give 335 mgs (28percent) of l-(4-bromophenyl)ethane-l,2-diol as a white solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | With sodium tetrahydroborate In ethanol at 0 - 20℃; for 12 h; | [0160] To a solution of ethyl2-(4-bromophenyl)-2-oxoacetate(LOg, 4.0 mmol) in ethanol (20 mL) was added sodiumborohydride (380 mg, 10.0 mmol) at oo C., and the mixturewas stirred at RT for 12 h. The reaction was quenched withpropan-2-one (1 0 mL) and concentrated under reduced pressure.The resultant was purified by silica gel column chromatography( dichloromethane:methanol= 10: 1) to afford thetitle compound (700 mg, 81percent) as a white solid. MS (ES+)C8H9Br02 requires: 216. found: 217, 219 [M+Ht. |
47% | at 0 - 20℃; for 0.166667 h; | To a 50 mL round-bottom flask were added ethyl 4-bromobenzoylformate (0.30 g, 1.2 mmol) and methanol (10 mL), then sodium borohydride (0.13 g, 0.41 mmol) was added in portions at 0°C. The resulting mixture was stirred at rt for 10 min. The reaction mixture was acidified with hydrochloric acid (5.0 mol/L) to pH 6, then the resulting mixture was concentrated in vacuo to remove the methanol. The residue was dissolved in water (50 mL), and the resulting mixture was extracted with ethyl acetate (30 mL*3). The combined organic layers were dried over anhydrous sodium sulfate, concentrated in vacuo, and the residue was purified by silica-gel column chromatography (DCM:MeOH=30:1, V/V) to give a white solid (0.12 g, 47percent). MS(ESI, pos.ion)m/z: 217.9 (M+2); |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With sodium tetrahydroborate In ethanol for 1 h; | General procedure: All racemic 1-phenyl-1,2-ethanediols were prepared in quantitative yields by the reduction of the corresponding substituted phenylglyoxal (1 mmol) with NaBH4 (2 mmol) in ethanol (7 mL) at 0 °C to room temperature for 1 h. After completion of the reaction the excess ethanol was removed. The reaction mixture was hydrolysed with dilute HCl and the mixture was extracted with ethyl acetate. The organic layer was dried, concentrated and purified by column chromatography. |
[ 34598-50-0 ]
5-Bromo-2,3-dihydro-1H-inden-1-ol
Similarity: 0.90
[ 75476-86-7 ]
6-Bromo-2,3-dihydro-1H-inden-1-ol
Similarity: 0.90
[ 34598-50-0 ]
5-Bromo-2,3-dihydro-1H-inden-1-ol
Similarity: 0.90
[ 75476-86-7 ]
6-Bromo-2,3-dihydro-1H-inden-1-ol
Similarity: 0.90
[ 34598-50-0 ]
5-Bromo-2,3-dihydro-1H-inden-1-ol
Similarity: 0.90
[ 75476-86-7 ]
6-Bromo-2,3-dihydro-1H-inden-1-ol
Similarity: 0.90